Old Web
English
Sign In
Acemap
>
authorDetail
>
Alireza Eghtedar
Alireza Eghtedar
University of Texas MD Anderson Cancer Center
Medicine
Immunology
Myeloid leukemia
Internal medicine
Leukemia
7
Papers
205
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Outcome After Failure of Second Generation Tyrosine Kinase Inhibitors Treatment As First-line Therapy for Patients With Chronic Myeloid Leukemia
2013
Clinical Lymphoma, Myeloma & Leukemia
Alireza Eghtedar
Hagop M. Kantarjian
Elias Jabbour
Susan OBrien
Elizabeth Burton
Guillermo Garcia-Manero
Srdan Verstovsek
Farhad Ravandi
Gautam Borthakur
Marina Konopleva
Alfonso Quintás-Cardama
Jorge E. Cortes
Show All
Source
Cite
Save
Citations (20)
Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia†
2012
American Journal of Hematology
Alireza Eghtedar
Gautam Borthakur
Farhad Ravandi
Elias Jabbour
Jorge E. Cortes
Sherry Pierce
Hagop M. Kantarjian
Guillermo Garcia-Manero
Show All
Source
Cite
Save
Citations (6)
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.
2012
Blood
Alireza Eghtedar
Srdan Verstovsek
Zeev Estrov
Jan Andreas Burger
Jorge E. Cortes
Carol Bivins
Stefan Faderl
Alessandra Ferrajoli
Gautam Borthakur
Solly George
Peggy Scherle
Robert C. Newton
Hagop M. Kantarjian
Farhad Ravandi
Show All
Source
Cite
Save
Citations (161)
1